28 results
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
in substantial costs and divert management time and resources. Additionally, if a plaintiff is successful in obtaining an injunction prohibiting consummation
6-K
EX-99.1
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
stockholder, Jason Gallanti (the “Canadian Plaintiff”), filed a statement of claim before the Ontario Superior Court of Justice against the Company … to disclosures concerning the Company’s Phase 2a RELIEF trial. The Canadian Plaintiff seeks certification of the action as a class proceeding on behalf
6-K
EX-99.2
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
in 2024, $51,456,000 in 2025 and $17,299,000 in 2026.
On July 6, 2022, a Company stockholder, Jason Gallanti (the “Canadian Plaintiff”), filed … . The Canadian Plaintiff seeks certification of the action as a class proceeding on behalf of those who purchased the Company’s stock on the TSX, leave to pursue
6-K
EX-99.1
BLU
Bellus Health Inc
29 Mar 23
Current report (foreign)
5:26pm
(“Plaintiff”), filed a complaint against the Company and certain of its executive officers alleging claims under provisions of the Securities Exchange Act … of 1934 (“Exchange Act”). On September 17, 2021, Plaintiff filed an amended class action complaint, individually and on behalf of all persons who
6-K
EX-99.2
BLU
Bellus Health Inc
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
will require an attestation report on ICFR for the year ended December 31, 2022.
On March 16, 2021, a Company stockholder, Carl D. Cachia (“Plaintiff … (“Exchange Act”). On September 17, 2021, Plaintiff filed an amended class action complaint, individually and on behalf of all persons who purchased
6-K
EX-99.1
7ubp7y
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
6-K
EX-99.1
kymdkezv
14 Nov 22
Open Market Sale Agreementsm
5:19pm
6-K
EX-99.1
s1ywwnhr qqn3
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.2
70l1o1grnb90m
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.2
aq7jyfn
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
6-K
EX-99.2
7ltvp2ch
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.1
dezubc
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.1
x32lego0
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.3
55luv5hjwg
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.2
mqk rd475t
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.1
0bdzq
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
1ql q6wqm25
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
6-K
EX-99.1
ojx44w19eoku
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
6-K
EX-99.2
znx1mxye5h9
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
6-K
EX-99.1
8prhowq yn85
23 Dec 20
Open Market Sale Agreementsm
5:06pm